vs
CVRx, Inc.（CVRX）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是CVRx, Inc.的1.0倍（$16.5M vs $16.0M），Finward Bancorp净利率更高（12.0% vs -74.5%，领先86.5%），CVRx, Inc.同比增速更快（4.4% vs 1.1%），Finward Bancorp自由现金流更多（$9.0M vs $-9.8M），过去两年CVRx, Inc.的营收复合增速更高（22.0% vs -19.1%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
CVRX vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.0倍
$16.0M
营收增速更快
CVRX
高出3.4%
1.1%
净利率更高
FNWD
高出86.5%
-74.5%
自由现金流更多
FNWD
多$18.9M
$-9.8M
两年增速更快
CVRX
近两年复合增速
-19.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $16.5M |
| 净利润 | $-11.9M | $2.0M |
| 毛利率 | 86.3% | — |
| 营业利润率 | -69.8% | 11.0% |
| 净利率 | -74.5% | 12.0% |
| 营收同比 | 4.4% | 1.1% |
| 净利润同比 | -12.0% | -5.6% |
| 每股收益（稀释后） | $-0.45 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXFNWD
| Q4 25 | $16.0M | $16.5M | ||
| Q3 25 | $14.7M | $17.4M | ||
| Q2 25 | $13.6M | $16.6M | ||
| Q1 25 | $12.3M | $15.5M | ||
| Q4 24 | $15.3M | $16.3M | ||
| Q3 24 | $13.4M | $14.9M | ||
| Q2 24 | $11.8M | $14.6M | ||
| Q1 24 | $10.8M | $25.3M |
净利润CVRXFNWD
| Q4 25 | $-11.9M | $2.0M | ||
| Q3 25 | $-12.9M | $3.5M | ||
| Q2 25 | $-14.7M | $2.2M | ||
| Q1 25 | $-13.8M | $455.0K | ||
| Q4 24 | $-10.7M | $2.1M | ||
| Q3 24 | $-13.1M | $606.0K | ||
| Q2 24 | $-14.0M | $143.0K | ||
| Q1 24 | $-22.2M | $9.3M |
毛利率CVRXFNWD
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | — | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | — | ||
| Q2 24 | 83.9% | — | ||
| Q1 24 | 85.0% | — |
营业利润率CVRXFNWD
| Q4 25 | -69.8% | 11.0% | ||
| Q3 25 | -83.5% | 20.5% | ||
| Q2 25 | -105.8% | 12.7% | ||
| Q1 25 | -108.8% | 4.0% | ||
| Q4 24 | -67.0% | 16.3% | ||
| Q3 24 | -97.3% | 2.7% | ||
| Q2 24 | -118.3% | 0.9% | ||
| Q1 24 | -206.4% | 40.6% |
净利率CVRXFNWD
| Q4 25 | -74.5% | 12.0% | ||
| Q3 25 | -87.6% | 20.1% | ||
| Q2 25 | -108.4% | 12.9% | ||
| Q1 25 | -111.5% | 2.9% | ||
| Q4 24 | -69.4% | 12.9% | ||
| Q3 24 | -98.0% | 4.1% | ||
| Q2 24 | -118.8% | 1.0% | ||
| Q1 24 | -206.0% | 36.7% |
每股收益（稀释后）CVRXFNWD
| Q4 25 | $-0.45 | $0.46 | ||
| Q3 25 | $-0.49 | $0.81 | ||
| Q2 25 | $-0.57 | $0.50 | ||
| Q1 25 | $-0.53 | $0.11 | ||
| Q4 24 | $-0.39 | $0.50 | ||
| Q3 24 | $-0.57 | $0.14 | ||
| Q2 24 | $-0.65 | $0.03 | ||
| Q1 24 | $-1.04 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $174.7M |
| 总资产 | $104.8M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXFNWD
| Q4 25 | $75.7M | — | ||
| Q3 25 | $85.1M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $102.7M | — | ||
| Q4 24 | $105.9M | — | ||
| Q3 24 | $100.2M | — | ||
| Q2 24 | $70.4M | — | ||
| Q1 24 | $80.1M | — |
股东权益CVRXFNWD
| Q4 25 | $39.3M | $174.7M | ||
| Q3 25 | $48.1M | $165.5M | ||
| Q2 25 | $57.9M | $154.3M | ||
| Q1 25 | $71.1M | $151.8M | ||
| Q4 24 | $71.1M | $151.4M | ||
| Q3 24 | $65.2M | $159.6M | ||
| Q2 24 | $55.2M | $148.6M | ||
| Q1 24 | $66.3M | $151.6M |
总资产CVRXFNWD
| Q4 25 | $104.8M | $2.0B | ||
| Q3 25 | $111.3M | $2.1B | ||
| Q2 25 | $119.6M | $2.1B | ||
| Q1 25 | $129.6M | $2.0B | ||
| Q4 24 | $133.4M | $2.1B | ||
| Q3 24 | $127.7M | $2.1B | ||
| Q2 24 | $96.0M | $2.1B | ||
| Q1 24 | $106.2M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | $9.0M |
| 自由现金流率自由现金流/营收 | -61.3% | 54.8% |
| 资本支出强度资本支出/营收 | 0.4% | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | $-40.8M | $10.6M |
8季度趋势，按日历期对齐
经营现金流CVRXFNWD
| Q4 25 | $-9.8M | $9.9M | ||
| Q3 25 | $-9.7M | $1.2M | ||
| Q2 25 | $-7.9M | $4.8M | ||
| Q1 25 | $-12.8M | $-3.8M | ||
| Q4 24 | $-8.0M | $9.8M | ||
| Q3 24 | $-10.4M | $-3.7M | ||
| Q2 24 | $-9.8M | $2.8M | ||
| Q1 24 | $-10.9M | $-25.0K |
自由现金流CVRXFNWD
| Q4 25 | $-9.8M | $9.0M | ||
| Q3 25 | $-10.0M | $1.0M | ||
| Q2 25 | $-8.0M | $4.5M | ||
| Q1 25 | $-12.9M | $-4.0M | ||
| Q4 24 | $-8.1M | $6.7M | ||
| Q3 24 | $-10.4M | $-4.2M | ||
| Q2 24 | $-10.2M | $1.1M | ||
| Q1 24 | $-11.8M | $-736.0K |
自由现金流率CVRXFNWD
| Q4 25 | -61.3% | 54.8% | ||
| Q3 25 | -68.1% | 6.0% | ||
| Q2 25 | -59.2% | 27.0% | ||
| Q1 25 | -104.3% | -25.7% | ||
| Q4 24 | -52.5% | 41.2% | ||
| Q3 24 | -78.1% | -28.5% | ||
| Q2 24 | -86.3% | 7.6% | ||
| Q1 24 | -109.7% | -2.9% |
资本支出强度CVRXFNWD
| Q4 25 | 0.4% | 5.2% | ||
| Q3 25 | 2.0% | 0.9% | ||
| Q2 25 | 0.8% | 1.7% | ||
| Q1 25 | 0.9% | 1.2% | ||
| Q4 24 | 0.3% | 18.8% | ||
| Q3 24 | 0.3% | 3.4% | ||
| Q2 24 | 3.0% | 11.2% | ||
| Q1 24 | 8.5% | 2.8% |
现金转化率CVRXFNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
FNWD
暂无分部数据
